Term ends Mar 13, 2027 · High confidence
20-year base term ends Jan 26, 2027
Held by Panion & BF Biotech Inc.
Filed Jan 12, 2015 as application 14/594,469 · Granted Jan 10, 2017
Base term plus 46 days of patent term adjustment (USPTO delay)
Today
2007
2027
Clock starts
Jan 26, 2007
Jan 26, 2007
Term ends
Mar 13, 2027
Mar 13, 2027
Granted
Jan 10, 2017
Jan 10, 2017
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
46
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 46 days past its 20-year base term on prosecution delay. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 26, 2007, when application PCT/US2007/002158, the earliest non-provisional in its chain, was filed (this one was filed Jan 12, 2015) | Jan 26, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +46 days, USPTO patent term adjustment record | Mar 13, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 13, 2027 | High confidence |
This family
| US 8,932,648 | In force Apr 2030 | Apr 2030 |
| US 9,539,284 | this patent Mar 2027 | Mar 2027 |
| Application 15/401,452 | Abandoned not computed | not computed |
3 of 4 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 30, 2016 Reel 40464, frame 673 | Chan, Keith | Globoasia, LLC | Assignment of Assignor's Interest |
| Nov 30, 2016 Reel 40464, frame 841 | Globoasia, LLC | Panion & BF Biotech Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2027
Term ends Mar 13, 2027. No further fees fall due before then
Note
The 46 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.